ToolGen툴젠
199800 · KOSDAQ · ₩199800 · 툴젠
- Market cap
- ₩272B
- Enterprise value
- ₩264B
- P/E
- —
- P/B
- 5.9×
- Dividend yield
- 0.0%
- ROE
- −74.6%
- Net margin
- −1,814.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−80.4% from the high
₩27,250Today: ₩27,250 – ₩28,050₩142,000
Returns
- 1W−6.5%
- 1M−17.5%
- 3M−34.3%
- 6M−69.3%
- YTD−52.5%
- 1Y−50.3%
- Volume today
- 6,534
- 0.2× the 20-day average
- Traded today
- ₩182M
- Listed shares
- 9,774,629
- EPS (12 months)
- −₩3,551
- Earnings yield −12.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Only a routine amended filing; no substantive news in the sources. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-14.6% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
ToolGen stock overview
ToolGen (툴젠, KRX: 199800) is listed on KOSDAQ, in the Biotech & Pharma sector. Toolgen Inc. Its shares closed at ₩27,850 on Oct 26, 2026, down 0.18% on the day, giving it a market value of ₩272B.
Key facts
- Market cap
- ₩272B
- Sector
- Biotech & Pharma
- Latest price change
- −0.18%
- As of
- Oct 26, 2026
- Main business
- Toolgen Inc.
Quick answers about ToolGen
- What does ToolGen do?
- Toolgen Inc. is a South Korean company and a developer of gene editing technology, operating in gene-editing research and development, a patent monetization business based on its gene-editing platform, and the development of therapeutics and seeds. It supplies CRISPR, ZFN and TALEN gene-editing tools, gene-edited cell lines and animals, sequencing services, and research services to life science customers, and its revenue is mainly derived from technology licensing, with a significant share from exports.
- What is the market cap of ToolGen?
- The market capitalisation of ToolGen was ₩272B at the close on Oct 26, 2026.
- Who are the largest shareholders of ToolGen?
- According to the latest official filings, the largest reported holders are Genexine (11.59%, as of Oct 2, 2026); National Pension Service (0.43%, as of Dec 31, 2021); Kwon Soon-il (0.05%, as of Oct 2, 2026).
- When is the next earnings report from ToolGen?
- Korean companies rarely announce results dates in advance. Based on when ToolGen filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own ToolGen?
- Yes. The National Pension Service held 0.43% of ToolGen shares as of Dec 31, 2021.
Company profile
Toolgen Inc. is a South Korean company and a developer of gene editing technology, operating in gene-editing research and development, a patent monetization business based on its gene-editing platform, and the development of therapeutics and seeds. It supplies CRISPR, ZFN and TALEN gene-editing tools, gene-edited cell lines and animals, sequencing services, and research services to life science customers, and its revenue is mainly derived from technology licensing, with a significant share from exports.
Written by AI from the company's latest annual report.
- Korean name
- 툴젠
- Sector
- Biotech & Pharma
- CEO
- 유종상
- Founded
- Oct 1999
- Listed
- Dec 2021
- Listed shares
- 9,774,629
- Fiscal year ends
- Month 12
- Website
- toolgen.com
Similar companies
- Samsung Biologics207940 · ₩67T₩1,452,000−0.95%
- Celltrion068270 · ₩44T₩190,000−2.26%
- Alteogen196170 · ₩15T₩218,500−2.67%
- Yuhan000100 · ₩6T₩81,700−3.54%
- SK biopharmaceuticals326030 · ₩5.9T₩75,800−1.43%
- HLB028300 · ₩5.2T₩39,250−5.65%
- Hanmi Pharm128940 · ₩4.5T₩352,500−2.49%
- SAM Chun Dang Pharm000250 · ₩4.4T₩188,900−5.17%
Recent filings
See all- Amended: Half-year report (Jun 2026)Oct 23, 2026
- 5%+ holding reportOct 2, 2026
- Insider shareholding reportOct 2, 2026
- Insider shareholding reportOct 2, 2026
- Insider shareholding reportOct 2, 2026
Titles in Korean until English translations are added.
Also known as: ToolGen / 툴젠 / 199800 / KRX:199800
Source: KRX statistical information